One publication from the last week:

• The value of genomic sequencing in complex pediatric neurological disorders: a discrete choice experiment | link

I’m happy to share any other publications from this week that I’ve missed – just let me know.

One publication this week:

• Next generation use in Oncology, a better information on patients’ genetic profiles improved access to matched treatments and earlier NGS use show better outcomes | link

I’m happy to share any other publications from this week that I’ve missed – just let me know.

Three publications this week:

• PARC report: health outcomes and value of personalized medicine interventions: impact on patient care | link
• The Daunting Economics of Therapeutic Genome Editing | link
• Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention | link

I’m happy to share any other publications from this week that I’ve missed – just let me know.

No publications last week, but five (well, kind of) this week:

• Costs of In-House Genomic Profiling and Implications for Economic Evaluation: A Case Example of Non-Small Cell Lung Cancer (NSCLC) | link
• Multi-gene Assays: Effect on Chemotherapy Use, Toxicity and Cost in Estrogen Receptor-Positive Early Stage Breast Cancer | link
• Ending the Diagnostic Odyssey—Is Whole-Genome Sequencing the Answer? | link
• Economic Value of Exome Sequencing for Suspected Monogenic Disorders [letter] | link
• Response to Ferket Et Al [response to letter] | link

I’m happy to share any other publications from this week that I’ve missed – just let me know.

No publications last week, but a glut of new publications related to multi-gene panels this week, four in total:

• Cost-Effectiveness of Multigene Pharmacogenetic Testing in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention | link
• Projected Cost-Effectiveness for 2 Gene-Drug Pairs Using a Multigene Panel for Patients Undergoing Percutaneous Coronary Intervention | link
• Cost Effectiveness of Multigene Panel Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer | link
• Incorporating Tumor Characteristics to Maximize 21-Gene Assay Utility: A Cost-Effectiveness Analysis | link

I’m happy to share any other publications from this week that I’ve missed – just let me know.

I’ve been sharing weekly updates of new publications in health economics and genomics on social media for a few weeks, but thought it would be useful if I also presented these updates in weekly blog posts.

There are 2 new publications this week:

• Estimating the Costs of Genomic Sequencing in Cancer Control | https://pubmed.ncbi.nlm.nih.gov/32493298/
• Next-Generation Sequencing vs Culture-Based Methods for Diagnosing Periprosthetic Joint Infection After Total Knee Arthroplasty: A Cost-Effectiveness Analysis | https://pubmed.ncbi.nlm.nih.gov/31005439/

As I’m putting these in a blog post for the first time, here are the latest publications from the past four weeks too: Continue reading →